Basel Medical Group Ltd (BMGL) stock
Close on Nov 12, 2026Market cap $901.80KP/E –Yield –
Basel Medical Group Ltd grew revenue 45.2% to 16.44M SGD over fiscal 2026. Free cash flow was -883.44K SGD. At the latest close the market valued the company at 1.16M SGD.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Jun 30, 2026
Valuation
- Market cap
- 1.16M SGD
- P/E ratio
- –
- Price to sales
- 0.07
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -76.41%
Fundamentals
- Revenue
- 16.44M SGD
- Net income
- -748.00K SGD
- EPS, diluted
- -0.78 SGD
- Free cash flow
- -883.44K SGD
Trading
- Previous close
- $0.68
- Open
- $0.60
- Day's range
- $0.51 – $0.65
- Volume
- 1,602,033
- Average volume (20 days)
- 2,358,018
- RSI (14 days)
- 19.0
- Volatility (1 year)
- 159.6%
- Relative volume
- 5.14×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BMGL | S&P 500 | Difference | BMGL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -84.6% | -2.7% | −81.9 pts | ||
| 3 months | -87.4% | -1.7% | −85.6 pts | ||
| Year to date | -90.3% | +11.9% | −102.2 pts | ||
| 1 year | -96.6% | +12.0% | −108.6 pts |
Four years at a glance
Fiscal years 2023 to 2026, SGD
Revenue
Net income
EPS, diluted
Free cash flow
Press releases
Releases Basel Medical filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Basel Medical
Services-Offices & Clinics of Doctors of Medicine
Basel Medical Group Ltd is a healthcare provider that specializes in orthopedic treatments and related medical services. The company focuses on the diagnosis, correction, prevention, and treatment of disorders affecting the musculoskeletal system, including bones, joints, muscles, ligaments, and tendons. Its operations encompass specialized orthopedic and sports clinics, physiotherapy services, and general medical care delivered through specialized practitioners, external medical professionals, and locum doctors. The organization primarily serves patients requiring orthopedic care, sports injury treatments, physiotherapy, and routine medical consultations.
Company profile, executives and historyBasel Medical stock: common questions
What is Basel Medical's stock price?
BMGL closed at $0.57 on Nov 12, 2026, down 16.67% on the day.
What is Basel Medical's market cap?
Basel Medical was worth $901.80K at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is BMGL's P/E ratio?
Basel Medical lost money over fiscal 2026 (diluted EPS -0.78 SGD), so it has no meaningful P/E ratio.
How much revenue does Basel Medical make?
Basel Medical reported revenue of 16.44M SGD for fiscal 2026, up 45.2% from a year earlier.
Does Basel Medical pay a dividend?
No. Basel Medical has not paid a cash dividend over the last twelve months.
How has BMGL stock performed over the past year?
Including dividends, BMGL returned -96.6% over the past year, against +12.0% for the S&P 500.
Who are Basel Medical's competitors?
Companies most similar to Basel Medical by business, industry and size include CDIX, SBC, LFMD, HLYK, CCM.
See a number that looks wrong?